Table 5.
HR (95% CI) | |||
---|---|---|---|
Variable | no GDM | GDM | LRT p for interaction of GDM & variable |
Glucose intolerancea | 0.4 | ||
Yes | 1.00 (reference) | 1.70 (0.71–4.07) | |
No | 1.00 (reference) | 2.98 (1.23–7.26) | |
Insulin resistanceb | 0.1 | ||
Yes | 1.00 (reference) | 1.23 (0.47–3.23) | |
No | 1.00 (reference) | 3.80 (1.69–8.55) | |
HOMA-IR | 0.6 | ||
>4 | 1.00 (reference) | 1.83 (0.75–4.44) | |
≤4 | 1.00 (reference) | 2.60 (1.08–6.28) | |
HOMA-IR | 0.3 | ||
≥2.73 | 1.00 (reference) | 1.77 (0.89–3.91) | |
<2.73 | 1.00 (reference) | 3.77 (1.41–10.13) | |
Metabolic syndromec | 0.5 | ||
Yes | 1.00 (reference) | 1.55 (0.55–4.35 | |
No | 1.00 (reference) | 2.50 (1.15–5.43) | |
Diabetes mellitus | 0.9 | ||
Yes | 1.00 (reference) | 2.05 (0.66–6.36) | |
No | 1.00 (reference) | 1.95 (0.87–4.37) | |
Hypertension | 0.3 | ||
Yes | 1.00 (reference) | 1.39 (0.47–4.10) | |
No | 1.00 (reference) | 2.94 (1.38–6.26) |
Note: 331 subjects contributed 948 observations to each model. Each subject can contribute one observation for each CARDIA exam year she has data available for the outcome.
Abbreviations: CARDIA, Coronary Artery Risk Development in Young Adults; CI, confidence interval; CKD, chronic kidney disease; GDM, gestational diabetes mellitus; HOMA-IR, Homeostatic Model Assessment of Insulin Resistance; HR, hazard ratio; LRT, likelihood ratio test